Product Specifications
cognition-orientated clinical trials: people with risk or diagnosed AD In a clinical trial in individuals at risk of AD, participants aged 45 to 70 years who did not have diabetes or a history of neurological disorders were recruited
People with uncontrolled diabetes may have nerve damage that slows digestion, leading to hard stools and straining during bowel movements
Cuzzolin, A., Deganutti, G., Salmaso, V., Sturlese, M
Source: Wind, 36Kr So, what has enabled tirzepatide to achieve long - term high growth in sales
The biggest selling point of peptides is cognitive performance enhancement: Peptides can increase concentration and energy levels through improved mitochondrial efficiency, improve stress resistance (e.g., via cortisol modulation), and positively influence sleep and recovery